Muñoz-Palacio Bernardo J, Syro Daniel, Pinzón Miguel A, Ramirez Beatriz, Betancur Juan F
Pulmonology, Clínica Medellín/Grupo QuirónSalud, Medellín, COL.
Anesthesiology and Reanimation, CES University, Medellín, COL.
Cureus. 2021 Nov 8;13(11):e19352. doi: 10.7759/cureus.19352. eCollection 2021 Nov.
Chest tomography has played an essential role during the coronavirus disease 2019 (COVID-19) pandemic since it has allowed to suspect and diagnose the disease early and to assess the severity of lung involvement, predict the disease's course, and detect the complications associated with it. Certain chest CT findings have been reported in more than 70% of reverse transcription polymerase chain reaction (RT-PCR) test-proven COVID-19 cases, including ground-glass opacities, vascular enlargement, bilateral abnormalities, lower lobe involvement, and posterior predilection. In COVID-19-endemic regions, observing these chest CT findings should raise the suspicion of a possible COVID-19 diagnosis. Rare reported CT findings in RT-PCR test-proven COVID-19 cases include pleural effusion, lymphadenopathy, tree-in-bud sign, central lesion distribution, pericardial effusion, and cavitating lung lesions. The observation of one or more of these findings suggests an alternative diagnosis, although COVID-19 cannot be excluded from the differential diagnosis. Here, we report an interesting case of a patient with no relevant history presenting a COVID-19 infection which, as a complication, presented cystic lesions; we discuss its etiology briefly.
在2019冠状病毒病（COVID-19）大流行期间，胸部断层扫描发挥了重要作用，因为它能够早期怀疑和诊断该疾病，并评估肺部受累的严重程度、预测疾病进程以及检测与之相关的并发症。在超过70%的经逆转录聚合酶链反应（RT-PCR）检测证实的COVID-19病例中报告了某些胸部CT表现，包括磨玻璃影、血管增粗、双侧异常、下叶受累以及后部偏好。在COVID-19流行地区，观察到这些胸部CT表现应引起对可能的COVID-19诊断的怀疑。在经RT-PCR检测证实的COVID-19病例中，罕见的报告CT表现包括胸腔积液、淋巴结肿大、树芽征、中央病变分布、心包积液和肺空洞病变。观察到这些表现中的一种或多种提示可能存在其他诊断，尽管在鉴别诊断中不能排除COVID-19。在此，我们报告一例无相关病史的患者感染COVID-19的有趣病例，该病例作为并发症出现了囊性病变；我们简要讨论其病因。
